Clinical Trial Update: Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial combining cisplatin, gemcitabine, and bevacizumab for metastatic bladder cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Christopher Sweeney, MBBS | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-14